Seeking Alpha

More on Sanofi (SNY +3.2%) Q2: adjusted net profit -9.6% to €1.94B, hurt by patent...

More on Sanofi (SNY +3.2%) Q2: adjusted net profit -9.6% to €1.94B, hurt by patent expirations for Plavo and Avapro. Plans to announce details of job cuts at two French units in September, putting it on a collision course with the government, which says it won't tolerate job losses at profitable companies.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs